NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
Deadline: January 7, 2028
Opportunity Number: PA-25-126
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
NICHD Small Research Grant Program (R03 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PA-25-125
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
Deadline: November 12, 2027
Opportunity Number: PAR-25-204
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.279
NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-164
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.121
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-105
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.121
NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-166
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.121
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-065
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242, 93.866
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-064
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.866, 93.242
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-039
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-040
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-095
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.121, 93.866, 93.393, 93.172
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-096
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.121, 93.866, 93.172, 93.393
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
Deadline: March 16, 2026
Opportunity Number: PA-25-246
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: March 16, 2026
Status: Posted
CFDA Numbers: 93.866
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-067
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-066
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-110
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.855, 93.279, 93.313, 93.242, 93.865
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-111
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.865, 93.855, 93.279, 93.313
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Deadline: February 8, 2027
Opportunity Number: RFA-MH-26-170
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: February 8, 2027
Status: Posted
CFDA Numbers: 93.273, 93.213, 93.866, 93.867, 93.242, 93.286, 93.853, 93.865, 93.173, 93.279
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Deadline: November 5, 2026
Opportunity Number: PAR-25-255
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: November 5, 2026
Status: Posted
CFDA Numbers: 93.399, 93.242, 93.172
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2027
Opportunity Number: PAR-25-256
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.399, 93.172
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-273
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.351
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Deadline: May 4, 2028
Opportunity Number: PA-25-168
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: May 4, 2028
Status: Posted
CFDA Numbers: 93.273, 93.865, 93.279, 93.172, 93.313, 93.351, 93.867, 93.310, 93.846, 93.838, 93.847, 93.113, 93.853, 93.397, 93.855, 93.213, 93.361, 93.286, 93.233, 93.242, 93.840, 93.399, 93.398, 93.837, 93.173, 93.121, 93.839, 93.866, 93.396, 93.859
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
Deadline: March 5, 2026
Opportunity Number: PAR-25-209
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: March 5, 2026
Status: Posted
CFDA Numbers: 93.866
Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
Deadline: April 20, 2027
Opportunity Number: RFA-ES-25-002
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: April 20, 2027
Status: Posted
CFDA Numbers: 93.113
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-203
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.859